Skip to main content
Neuro-Oncology logoLink to Neuro-Oncology
. 2018 Sep 19;20(Suppl 3):iii317. doi: 10.1093/neuonc/noy139.388

P05.62 Post-operative cardiovascular complications and time to recurrence in meningioma patients treated with versus without pre-operative embolization: a retrospective cohort study of 741 patients

H Wirsching 1
PMCID: PMC6144592

Abstract

Background

Preoperative embolization of radiographically suspected meningiomas is often performed to facilitate subsequent tumor resection. Its effects on the post-operative course of operated meningiomas have not been studied in detail and randomized trials are lacking. The objective of this study was to explore associations of preoperative meningioma embolization with postoperative outcome.

Patients and Methods

Patients undergoing resection of an intracranial meningioma at a single tertiary center 2000–2013 (N=741) were reviewed for the inclusion of pre-operative embolization in the management strategy. Annotations included demographics, radiographic, surgical, histological and hematological parameters, cardiovascular risk factors, pre- and postoperative neurological function and gene methylation-based classification. Binary regression and Cox proportional hazards models were applied to determine factors associated with outcome.

Results

Pre-operative embolization was performed in 337 patients (42%). Cardiovascular events after surgery comprised mostly deep vein thrombosis (N=39) and pulmonary embolisms (N=64). On multivariate analyses of post-operative cardiovascular adverse events controlling for established risk factors, there were associations with embolization (OR 2.38, 95% CI 1.37–4.00), and with female gender (OR 2.18, 95% CI 1.17–4.08). Recurrence-free survival (RFS) of embolized patients was less favorable among patients with WHO grade II or grade III meningiomas (median RFS: 4.3 versus 7.0 years, P=.029) or in patients with intermediate or malignant gene methylation subtype meningiomas (median RFS: 2.0 versus 8.2 years, P=.005), including in a multivariate Cox regression model that controlled for established risk factors.

Conclusion

Pre-operative meningioma embolization may cause adverse surgical outcomes. Randomized trials to determine benefit-risk ratios are warranted to clarify the role of pre-operative embolization for meningioma surgery.


Articles from Neuro-Oncology are provided here courtesy of Society for Neuro-Oncology and Oxford University Press

RESOURCES